Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
13.47
-0.94 (-6.52%)
Dec 3, 2024, 1:44 PM EST - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $1.23 billion as of December 3, 2024. Its market cap has decreased by -37.63% in one year.
Market Cap
1.23B
Enterprise Value
1.10B
1-Year Change
-37.63%
Ranking
Category
Stock Price
$13.47
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $1.23B, an increase of 1,188.64%. That is a compound annual growth rate of 29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 29, 2024 | 1.31B | -51.45% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Progyny | 1.33B |
| AdaptHealth | 1.32B |
| Pulse Biosciences | 1.32B |
| CareDx | 1.32B |
| Mesoblast | 1.32B |
| Establishment Labs Holdings | 1.28B |
| BioLife Solutions | 1.27B |
| Aurinia Pharmaceuticals | 1.27B |